loadpatents
name:-0.016289949417114
name:-0.01186990737915
name:-0.0047640800476074
Reedtz-Runge; Steffen Patent Filings

Reedtz-Runge; Steffen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Reedtz-Runge; Steffen.The latest application filed is for "gip derivatives and uses thereof".

Company Profile
4.11.12
  • Reedtz-Runge; Steffen - Bikeroed DK
  • Reedtz-Runge; Steffen - Birkeroed DK
  • Reedtz-Runge; Steffen - Frederiksberg DK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Gip Derivatives And Uses Thereof
App 20220000982 - Hogendorf; Wouter Frederik Johan ;   et al.
2022-01-06
Bifunctional compounds
Grant 11,130,794 - Tornoee , et al. September 28, 2
2021-09-28
Bifunctional compounds
App 20200231645 - Tornoee; Christian Wenzel ;   et al.
2020-07-23
GIP derivatives and uses thereof
Grant 10,604,555 - Hogendorf , et al.
2020-03-31
Gip Derivatives And Uses Thereof
App 20190367578 - Hogendorf; Wouter Frederik Johan ;   et al.
2019-12-05
GLP-1 derivatives and uses thereof
Grant 10,195,255 - Reedtz-Runge , et al. Fe
2019-02-05
Derivatives of GLP-1 like peptides, and uses thereof
Grant 10,010,614 - Reedtz-Runge , et al. July 3, 2
2018-07-03
Stable GLP-1 based GLP-1/glucagon receptor co-agonists
Grant 9,988,430 - Reedtz-Runge , et al. June 5, 2
2018-06-05
Truncated GLP-1 derivatives and their therapeutical use
Grant 9,657,079 - Spetzler , et al. May 23, 2
2017-05-23
Derivatives of GLP-1 Like Peptides, and Uses Thereof
App 20170007707 - Reedtz-Runge; Steffen ;   et al.
2017-01-12
Derivatives of GLP-1 like peptides, and uses thereof
Grant 9,498,534 - Reedtz-Runge , et al. November 22, 2
2016-11-22
Glucagon-like peptide-1 derivatives and their pharmaceutical use
Grant 9,409,966 - Spetzler , et al. August 9, 2
2016-08-09
GLP-1 Derivatives and Uses Thereof
App 20160143998 - Reedtz-Runge; Steffen ;   et al.
2016-05-26
Stable GLP-1 Based GLP-1/Glucagon Receptor Co-Agonists
App 20160102129 - Reedtz-Runge; Steffen ;   et al.
2016-04-14
Peptides derivatized with A-B-C-D- and their therapeutical use
Grant 9,067,977 - Spetzler , et al. June 30, 2
2015-06-30
Glucagon-like Peptide-1 Derivatives And Their Pharmaceutical Use
App 20150025003 - Spetzler; Jane ;   et al.
2015-01-22
Derivatives Of Glp-1 Like Peptides, And Uses Thereof
App 20150011462 - Reedtz-Runge; Steffen ;   et al.
2015-01-08
Glucagon-Like Peptide-1 derivatives and their pharmaceutical use
Grant 8,895,694 - Spetzler , et al. November 25, 2
2014-11-25
Truncated GLP-1 Derivatives and Their Therapeutical Use
App 20140296131 - Spetzler; Jane ;   et al.
2014-10-02
Peptides Derivatized with A-B-C-D- and their Therapeutical Use
App 20140011732 - Spetzler; Jane ;   et al.
2014-01-09
Truncated Glp-1 Derivaties And Their Therapeutical Use
App 20100292133 - Spetzler; Jane ;   et al.
2010-11-18
Peptides Derivatized With A-b-c-d- And Their Therapeutical Use
App 20100261637 - Spetzler; Jane ;   et al.
2010-10-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed